Cargando…

MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer

OBJECTIVE: To study the potential role of miR-544 in the immune escape mechanism of hepatoma cells. METHODS: Natural killer (NK) cells were collected from healthy volunteers and patients with liver cancer. Interleukin (IL)-2 activated-NK-92 cells were transfected with miR-544 inhibitor/mimic or NC/p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Chenwei, Xiang, Luxia, Pan, Zhenzhen, Wang, Xiaodong, Li, Jie, Zhuge, Lu, Fang, Peipei, Xie, Qipeng, Hu, Xuezhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883289/
https://www.ncbi.nlm.nih.gov/pubmed/29636640
http://dx.doi.org/10.1186/s12935-018-0542-y
_version_ 1783311618455633920
author Pan, Chenwei
Xiang, Luxia
Pan, Zhenzhen
Wang, Xiaodong
Li, Jie
Zhuge, Lu
Fang, Peipei
Xie, Qipeng
Hu, Xuezhen
author_facet Pan, Chenwei
Xiang, Luxia
Pan, Zhenzhen
Wang, Xiaodong
Li, Jie
Zhuge, Lu
Fang, Peipei
Xie, Qipeng
Hu, Xuezhen
author_sort Pan, Chenwei
collection PubMed
description OBJECTIVE: To study the potential role of miR-544 in the immune escape mechanism of hepatoma cells. METHODS: Natural killer (NK) cells were collected from healthy volunteers and patients with liver cancer. Interleukin (IL)-2 activated-NK-92 cells were transfected with miR-544 inhibitor/mimic or NC/pre-NC in HepG2 co-culture system. NK-92 cells were treated with control, IL-2, IL-2 + pre-NC, IL-2 + miR-544 mimic, IL-2 + miR-544 mimic + pcDNA and IL-2 + miR-544 mimic + pcDNA-runt-related transcription factor 3 (RUNX3) groups. Mice models of liver cancer were well established. Expression of miR-544, natural cytotoxicity receptor 1 (NCR1) and RUNX3 were evaluated by quantitative real-time PCR and western blotting. Flow cytometry and ELISA were used to determine NK cell cytotoxicity and the levels of INF-γ, respectively. RESULTS: MiR-544 was upregulated while NCR1 and RUNX3 was downregulated in NK cells of patients with liver cancer. The levels of IFN-γ and miR-544 expression were increased and decreased in IL-2 activated-NK cells, respectively. Inversely, miR-544 overexpression inhibited NK cell cytotoxicity by downregulating IFN-γ. However, miR-544 directly targeted RUNX3 and negatively regulated NCR1. Furthermore, miR-544 promoted immune escape of hepatoma cells in vivo and in vitro. CONCLUSION: miR-544 promoted the immune escape of liver cancer cells by downregulating NCR1 via targeting RUNX3.
format Online
Article
Text
id pubmed-5883289
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58832892018-04-10 MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer Pan, Chenwei Xiang, Luxia Pan, Zhenzhen Wang, Xiaodong Li, Jie Zhuge, Lu Fang, Peipei Xie, Qipeng Hu, Xuezhen Cancer Cell Int Primary Research OBJECTIVE: To study the potential role of miR-544 in the immune escape mechanism of hepatoma cells. METHODS: Natural killer (NK) cells were collected from healthy volunteers and patients with liver cancer. Interleukin (IL)-2 activated-NK-92 cells were transfected with miR-544 inhibitor/mimic or NC/pre-NC in HepG2 co-culture system. NK-92 cells were treated with control, IL-2, IL-2 + pre-NC, IL-2 + miR-544 mimic, IL-2 + miR-544 mimic + pcDNA and IL-2 + miR-544 mimic + pcDNA-runt-related transcription factor 3 (RUNX3) groups. Mice models of liver cancer were well established. Expression of miR-544, natural cytotoxicity receptor 1 (NCR1) and RUNX3 were evaluated by quantitative real-time PCR and western blotting. Flow cytometry and ELISA were used to determine NK cell cytotoxicity and the levels of INF-γ, respectively. RESULTS: MiR-544 was upregulated while NCR1 and RUNX3 was downregulated in NK cells of patients with liver cancer. The levels of IFN-γ and miR-544 expression were increased and decreased in IL-2 activated-NK cells, respectively. Inversely, miR-544 overexpression inhibited NK cell cytotoxicity by downregulating IFN-γ. However, miR-544 directly targeted RUNX3 and negatively regulated NCR1. Furthermore, miR-544 promoted immune escape of hepatoma cells in vivo and in vitro. CONCLUSION: miR-544 promoted the immune escape of liver cancer cells by downregulating NCR1 via targeting RUNX3. BioMed Central 2018-04-03 /pmc/articles/PMC5883289/ /pubmed/29636640 http://dx.doi.org/10.1186/s12935-018-0542-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Primary Research
Pan, Chenwei
Xiang, Luxia
Pan, Zhenzhen
Wang, Xiaodong
Li, Jie
Zhuge, Lu
Fang, Peipei
Xie, Qipeng
Hu, Xuezhen
MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer
title MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer
title_full MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer
title_fullStr MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer
title_full_unstemmed MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer
title_short MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer
title_sort mir-544 promotes immune escape through downregulation of ncr1/nkp46 via targeting runx3 in liver cancer
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883289/
https://www.ncbi.nlm.nih.gov/pubmed/29636640
http://dx.doi.org/10.1186/s12935-018-0542-y
work_keys_str_mv AT panchenwei mir544promotesimmuneescapethroughdownregulationofncr1nkp46viatargetingrunx3inlivercancer
AT xiangluxia mir544promotesimmuneescapethroughdownregulationofncr1nkp46viatargetingrunx3inlivercancer
AT panzhenzhen mir544promotesimmuneescapethroughdownregulationofncr1nkp46viatargetingrunx3inlivercancer
AT wangxiaodong mir544promotesimmuneescapethroughdownregulationofncr1nkp46viatargetingrunx3inlivercancer
AT lijie mir544promotesimmuneescapethroughdownregulationofncr1nkp46viatargetingrunx3inlivercancer
AT zhugelu mir544promotesimmuneescapethroughdownregulationofncr1nkp46viatargetingrunx3inlivercancer
AT fangpeipei mir544promotesimmuneescapethroughdownregulationofncr1nkp46viatargetingrunx3inlivercancer
AT xieqipeng mir544promotesimmuneescapethroughdownregulationofncr1nkp46viatargetingrunx3inlivercancer
AT huxuezhen mir544promotesimmuneescapethroughdownregulationofncr1nkp46viatargetingrunx3inlivercancer